Press Release
Committee Continues Investigation into Drug Pricing, Seeks Documents from FDA on Generics Applications
WASHINGTON—After months of reviewing the drug approval process and consumer price increases, Oversight Committee Chairman Jason Chaffetz (R-UT), along with 12 Committee members, sent a letter to U.S. Food and Drug Administration (FDA) Acting Director Stephen Ostroff, M.D. today, requesting documents and information on the FDA’s process for ...